Imunon Inc. (IMNN)
NASDAQ: IMNN
· Real-Time Price · USD
0.92
-0.10 (-9.80%)
At close: Jun 23, 2025, 3:59 PM
0.91
-1.54%
After-hours: Jun 23, 2025, 07:58 PM EDT
-9.80% (1D)
Bid | 0.9 |
Market Cap | 18.78M |
Revenue (ttm) | n/a |
Net Income (ttm) | -17.79M |
EPS (ttm) | -1.38 |
PE Ratio (ttm) | -0.67 |
Forward PE | -1.79 |
Analyst | Buy |
Ask | 0.96 |
Volume | 1,375,942 |
Avg. Volume (20D) | 11,230,912 |
Open | 0.99 |
Previous Close | 1.02 |
Day's Range | 0.92 - 1.01 |
52-Week Range | 0.37 - 3.65 |
Beta | 2.14 |
About IMNN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol IMNN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for IMNN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 days ago
-11.5%
IMUNON shares are trading lower. The company annou...
Unlock content with
Pro Subscription
3 weeks ago
+95.69%
Imunon shares are trading higher after the company announced it will present IMNN-001 data based on its immune biomarker analysis from its Phase 2 OVATION 2 study at ESMO Gynaecological Cancers Congress 2025